Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
<h4>Background</h4>ADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous treatment for intensive care pa...
Main Authors: | L Kaps, C J Ahlbrand, R Gadban, M Nagel, C Labenz, P Klimpke, S Holtz, S Boedecker, M Michel, W M Kremer, M Hilscher, P R Galle, D Kraus, J M Schattenberg, J Weinmann-Menke |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0249342 |
Similar Items
-
Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
by: Leonard Kaps, et al.
Published: (2022-05-01) -
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
by: Michael Nagel, et al.
Published: (2023-04-01) -
COVID-19—Importance for Patients on the Waiting List and after Kidney Transplantation—A Single Center Evaluation in 2020–2021
by: Simone C. Boedecker, et al.
Published: (2021-04-01) -
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
by: Maurice Michel, et al.
Published: (2021-10-01) -
Jurisprudencia del H. Tribunal Contencioso Advo.
by: Revista Estudios de Derecho
Published: (1953-05-01)